Ameriprise
FLNA

Ameriprise’s Filana Therapeutics FLNA Stock Holding History

Ameriprise’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,374
Closed -$23.1K – 4108
2025
Q1 		$23.1K Sell
15,374
-599
-4% -$1.51K ﹤0.01% 3976
2024
Q4 		$37.7K Sell
15,973
-1,963
-11% -$34.5K ﹤0.01% 4022
2024
Q3 		$528K Sell
17,936
-2,065
-10% -$47.6K ﹤0.01% 3461
2024
Q2 		$247K Buy
20,001
+3,543
+22% +$74.7K ﹤0.01% 3641
2024
Q1 		$334K Sell
16,458
-645
-4% -$14.9K ﹤0.01% 3553
2023
Q4 		$385K Sell
17,103
-2,500
-13% -$52.8K ﹤0.01% 3543
2023
Q3 		$326K Sell
19,603
-7,499
-28% -$149K ﹤0.01% 3562
2023
Q2 		$665K Sell
27,102
-5,672
-17% -$137K ﹤0.01% 3335
2023
Q1 		$791K Buy
32,774
+25,293
+338% +$701K ﹤0.01% 3254
2022
Q4 		$221K Buy
7,481
+370
+5% +$13.3K ﹤0.01% 3683
2022
Q3 		$298K Buy
+7,111
New +$192K ﹤0.01% 3584
2022
Q1 		– Sell
-6,060
Closed -$265K – 4014
2021
Q4 		$265K Sell
6,060
-5,510
-48% -$289K ﹤0.01% 3721
2021
Q3 		$718K Buy
11,570
+5,519
+91% +$461K ﹤0.01% 3284
2021
Q2 		$517K Sell
6,051
-8,642
-59% -$463K ﹤0.01% 3449
2021
Q1 		$661K Buy
14,693
+2,460
+20% +$96.8K ﹤0.01% 3304
2020
Q4 		$83K Buy
+12,233
New +$109K ﹤0.01% 3700
2018
Q2 		– Sell
-11,300
Closed -$80K – 3687
2018
Q1 		$80K Buy
+11,300
New +$76.3K ﹤0.01% 3569
2014
Q4 		– Sell
-13
Closed – – 4272
2014
Q3 		$0 Hold
13
– – ﹤0.01% 5880
2014
Q2 		$1K Hold
13
– – ﹤0.01% 5371
2014
Q1 		$0 Hold
13
– – ﹤0.01% 5389
2013
Q4 		$0 Buy
+13
New +$345 ﹤0.01% 5386

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Ameriprise's FLNA Position: Q2 2025 in Review

Ameriprise sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 15,374 shares — an estimated $23.1K sold.

Ameriprise first reported a position in FLNA in Q4 2013 and held it in 21 quarters. The position peaked at $791K in Q1 2023. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

  • Ameriprise reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Ameriprise sold 15,374 Filana Therapeutics shares in Q2 2025, an estimated $23.1K.
  • Ameriprise first reported a position in Filana Therapeutics in Q4 2013 and held it in 21 quarters.
  • Ameriprise's Filana Therapeutics position peaked at $791K in Q1 2023.
  • 97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.